SBFM - Sunshine Biopharma Inc.
1.27
-0.040 -3.150%
Share volume: 93,521
Last Updated: 05-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$1.31
-0.04
-0.03%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | |
|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 05-20-2024 | 08-20-2024 | 11-05-2024 | |
| Total revenue | 7.541 M | 9.303 M | 8.435 M | |
| Cost of revenue | 5.187 M | 6.947 M | 5.569 M | |
| Gross profit | 2.354 M | 2.356 M | 2.866 M | |
| 0.08% | 21.64% | |||
| Operating expenses | 574.039 K | 524.629 K | 1.257 M | |
| Selling general and admin | 352.006 K | 88.394 K | 1.130 M | |
| Research and development | 222.033 K | 436.235 K | 126.362 K | |
| Total expenses | 3.705 M | 3.625 M | 3.973 M | |
| -2.17% | 9.60% | |||
| Operating income | -1.351 M | -1.268 M | -1.106 M | |
| Ebit | -1.356 M | -981.741 K | -1.091 M | |
| Pretax income | -1.261 M | -837.991 K | -982.586 K | |
| -33.57% | 17.25% | |||
| Income tax | 22.353 K | -343.691 K | 215.217 K | |
| Net income basic | 0.000 | 0.000 | 0.000 | |
| Net income | -1.284 M | -494.300 K | -1.198 M | |
| 61.50% | -142.32% |
